Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transipeg vs Forlax Junior in Children With Constipation
NCT01810653Phase 4Completed
- Sponsor
- Bayer
- Start
- Apr 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of TransipegLib in functional constipation (FC) (2 arms), sponsored by Bayer. Primary endpoints: Symptom Based Weekly Total Sum Score at 52 weeks, Change From Baseline in Total Sum Score at 52 weeks and 5 more. Started Apr 2006; status: completed.
02
Drugs
TransipegLib
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT01810653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810653.